Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction

MGD-Meibomian Gland Dysfunction Clinical Trial

Official title: Efficacy of Adjunctive Low-Level Light Therapy to Intense Pulsed Light for Meibomian Gland Dysfunction

Status Not yet recruiting

Clinical Trial Summary

The goal of this clinical trial is to compare the effectiveness of adjunctive low-level light therapy (LLLT) to intense pulsed light (IPL) versus intense pulsed light (IPL) alone for the treatment of meibomian gland dysfunction (MGD).

The main question it aims to answer is does the adjunctive of low-level light therapy (LLLT) to intense pulsed light (IPL) provide more beneficial treatment effects than intense pulsed light (IPL) alone in treating meibomian gland dysfunction (MGD) patients?

Participants will be randomized into 2 groups: adjunctive low-level light therapy (LLLT) to intense pulsed light (IPL) group (ALLLT +IPL) and IPL alone group.

Clinical Trial Description

In both the IPL group and the ALLLT+IPL group, the doctor will administer IPL therapy to each participant and apply the Light Modulation® special facial mask to their faces. The assistant nurse will activate the light power, ensuring that the doctor remains blind to treatment allocation. Participants in both groups will receive a conventional treatment for MGD including warm compression and lid hygiene. Moreover, all participants will be advised to use preservative-free artificial tears 4 times daily throughout the study. ;

Related Conditions & MeSH terms

• Meibomian Gland Dysfunction
• MGD-Meibomian Gland Dysfunction

• NCT number: NCT06468930
• Study type: Interventional
• Source: Chulalongkorn University
• Contact: Chatchada Kharuhayothin
• Phone: +66922496151
• Email: chatchada.kharuhayothin@gmail.com
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 2024
• Completion date: February 2025